Rosemary Harrison - Jan 10, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Business & Strategy
Signature
/s/ Margaret Siegel as Attorney-In-Fact
Stock symbol
TCRR
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
4
Date filed
1/12/2022, 05:57 AM
Previous filing
Nov 19, 2021
Next filing
Dec 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +191K $0.00 191K Jan 10, 2022 Common Stock 191K $4.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 10, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.